Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
Orthofix Medical (NASDAQ:OFIX) has scheduled the release of its fourth quarter and full-year 2024 financial results for Tuesday, February 25, 2025, before the market opens. The company will host a conference call and webcast at 8:30 am Eastern Time on the same day to discuss the results.
Participants can join the conference call by dialing (888) 596-4144 in the U.S. and (646) 968-2525 from other locations, using the event passcode 5184023. The webcast and earnings release will be available on the company's investor relations website at ir.Orthofix.com.
Orthofix Medical (NASDAQ:OFIX) ha programmato la divulgazione dei suoi risultati finanziari per il quarto trimestre e per l’intero anno 2024 per martedì 25 febbraio 2025, prima dell'apertura del mercato. L'azienda ospiterà una conference call e un webcast alle 8:30 ora orientale nello stesso giorno per discutere i risultati.
I partecipanti possono unirsi alla conference call componendo (888) 596-4144 negli Stati Uniti e (646) 968-2525 da altre località, utilizzando il codice evento 5184023. Il webcast e il comunicato sui risultati saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda all'indirizzo ir.Orthofix.com.
Orthofix Medical (NASDAQ:OFIX) ha programado la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024 para el martes 25 de febrero de 2025, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica y un webcast a las 8:30 a.m. hora del este el mismo día para discutir los resultados.
Los participantes pueden unirse a la conferencia telefónica marcando (888) 596-4144 en EE. UU. y (646) 968-2525 desde otras ubicaciones, utilizando el código de acceso del evento 5184023. El webcast y el comunicado de ganancias estarán disponibles en el sitio web de relaciones con inversionistas de la compañía en ir.Orthofix.com.
Orthofix Medical (NASDAQ:OFIX)는 2025년 2월 25일, 즉 화요일에 2024년 4분기 및 연간 재무 결과 발표를 시장 개장 전에 예정하고 있습니다. 회사는 같은 날 오전 8시 30분(동부 표준시)에 결과에 대해 논의하는 컨퍼런스 콜 및 웹캐스트를 진행할 것입니다.
참가자는 미국에서 (888) 596-4144로, 기타 지역에서는 (646) 968-2525로 전화를 걸어 컨퍼런스 콜에 참여할 수 있으며, 이벤트 패스코드 5184023를 사용해야 합니다. 웹캐스트와 실적 발표는 회사의 투자자 관계 웹사이트 ir.Orthofix.com에서 확인할 수 있습니다.
Orthofix Medical (NASDAQ:OFIX) a prévu la publication de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le mardi 25 février 2025, avant l'ouverture des marchés. L'entreprise organisera une conférence téléphonique et un webcast à 8h30, heure de l'Est, le même jour pour discuter des résultats.
Les participants peuvent rejoindre la conférence téléphonique en composant (888) 596-4144 aux États-Unis et (646) 968-2525 depuis d'autres localités, en utilisant le code d'accès à l'événement 5184023. Le webcast et le communiqué de résultats seront disponibles sur le site web des relations investisseurs de l'entreprise à ir.Orthofix.com.
Orthofix Medical (NASDAQ:OFIX) hat die Veröffentlichung seiner Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 für Dienstag, den 25. Februar 2025, vor Marktöffnung angesetzt. Das Unternehmen wird am selben Tag um 8:30 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen.
Teilnehmer können sich in die Telefonkonferenz einwählen, indem sie in den USA (888) 596-4144 und aus anderen Regionen (646) 968-2525 anrufen und den Veranstaltungs-Zugangscode 5184023 verwenden. Der Webcast und die Gewinnmitteilung werden auf der Investor-Relations-Website des Unternehmens unter ir.Orthofix.com verfügbar sein.
- None.
- None.
Company to Host Conference Call on Tuesday, February 25, 2025 at 8:30 am ET
Interested parties may access the conference call by dialing (888) 596-4144 in the
Internet Posting of Information
Orthofix routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.
About Orthofix
Orthofix is a global medical technology company headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250128865236/en/
Investor Relations
Julie Dewey, IRC
Chief Investor Relations & Communications Officer
JulieDewey@Orthofix.com
209.613.6945
Media Relations
Denise Landry
DeniseLandry@Orthofix.com
214.937.2529
Source: Orthofix Medical Inc.
FAQ
When will Orthofix (OFIX) release Q4 and full-year 2024 earnings?
What time is Orthofix's (OFIX) Q4 2024 earnings call?
How can investors access Orthofix's (OFIX) Q4 2024 earnings call?